Florida H0573 mandates a study on discounted drug pricing for Medicaid recipients.
Florida H0573 requires the Agency for Health Care Administration to conduct or contract for a study on discounted drug pricing. The study must examine the impact of the 340B Drug Pricing Program on Medicaid recipients. It mandates that Medicaid pharmacies, pharmacy benefits managers, drug wholesalers, and distributors adhere to specific pricing rules. The study results must be submitted to the Governor and the Legislature by January 31, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.